News
VTRS
11.16
-1.80%
-0.21
Weekly Report: what happened at VTRS last week (0506-0510)?
Weekly Report · 1d ago
8 out of 12 S&P 500 healthcare companies beat profit consensus this week: Earnings Scorecard
Seeking Alpha · 2d ago
Organon Graduates From Spinoff Skepticism, With A Yield Above 5%
Organon, Pfizer, and Bristol Myers all offer yields above 5% and can compete with most Treasuries. Merck spun off Organon on June 3, 2021. The company is up over 40% YTD. Organon is micromanaging Merck's products and global footprint.
Seeking Alpha · 3d ago
About 70% of S&P 500 names beat EPS, while 47% soar past revenue estimates this week - Earnings Scorecard
About 70% of S&P 500 names beat EPS, while 47% soar past revenue estimates this week. Walt Disney posted a beat on EPS and a miss on revenue during its second-quarter earnings. Of the 61 companies that reported this week, 43 had EPS above analyst expectations.
Seeking Alpha · 4d ago
VIATRIS INC. AND SUBSIDIARIES: FORM 10-Q FOR THE QUARTERLY PERIOD ENDED MARCH 31, 2024
Press release · 4d ago
VIATRIS INC <VTRS.O>: UBS CUTS TARGET PRICE TO $12 FROM $13
Reuters · 4d ago
Analysts Offer Insights on Healthcare Companies: Health Catalyst (HCAT), Bluebird Bio (BLUE) and Viatris (VTRS)
TipRanks · 4d ago
U.S. RESEARCH ROUNDUP- Cerence, Epam Systems, Progyny
Wall Street analysts revise their ratings and price targets on several U.S.-listed companies. Cerence, Epam Systems and Progyny are among the companies. Analysts cut ratings and target prices on several of the companies on Friday. The analysts also cut their ratings on several other companies.
Reuters · 4d ago
Weak Sales From Lipitor, Norvasc Hurt Viatris' Q1 Earnings, Lowers Annual Forecast
Viatris Inc reports first-quarter sales of $3.66 billion, missing the consensus. The company says growth is driven by new product launches in Emerging Markets and Europe. Viatris expects 2024 adjusted EPS of $2.81. Sales of Lipitor and Norvasc fell 5%.
Benzinga · 5d ago
BUZZ-U.S. STOCKS ON THE MOVE-Hilton Grand Vacations, natgas firms, Silvaco
Main U.S. Stock indexes rose on Thursday. Dow Jones Industrial Average up 0.65% at 39,309.01. Top three S&P 500 percentage gainers and top three percentage losers. Weekly jobless claims data offered fresh evidence of a softening U.s. Labor market.
Reuters · 5d ago
Viatris declares $0.12 dividend
Dividend Stocks News Viatris declares $0.12 dividend May 09, 2024 2:16 PM ETViatris Inc. (VTRS) Stock. Forward yield 4.27% Payable June 14; for shareholders of record May 24; ex-div May 23.
Seeking Alpha · 5d ago
Stocks Rebound As Rising Jobless Claims Sustain Rate-Cut Hopes, Dollar Falls, Gold Rallies: What's Driving Markets Thursday?
All major US indices traded in the green around noon in New York. Jobless benefits rose to highest level in eight months, prompting speculation of a September Fed interest rate cut. The S&P 500 index inched up 0.1% and the Dow Jones Industrial Average climbed 0.4%.
Benzinga · 5d ago
BUZZ-U.S. STOCKS ON THE MOVE-Gold miners, Energy Transfer, Aercap
Main U.S. Stock indexes rose on Thursday. Dow Jones Industrial Average up 0.43% at 39,225.96. Top three S&P 500 percentage gainers: Equinix, Home Depot, Energy Transfer. Weekly jobless claims data showed fresh evidence of softening labor market in the United States.
Reuters · 5d ago
VTRS Stock Earnings: Viatris Meets EPS, Misses Revenue for Q1 2024
Viatris reported earnings per share of 67 cents for the first quarter of 2024. The company reported revenue of $3.66 billion. This was 1% worse than the analyst estimate for the same period. Viatris also reported results for the second quarter of 2016.
Investorplace · 5d ago
Stocks Close Higher on Fed Rate Cut Optimism
US stock indexes on Thursday settled higher, with the S&P 500 climbing to a 1-month high. Bond yields fell after US weekly initial unemployment claims rose more than expected to an 8-1/2 month high. Q1 earnings results have been mostly better than expected, a supportive factor for stocks. Overseas stock markets in Europe and China settled mixed.
Barchart · 5d ago
Viatris' (VTRS) Q1 Earnings & Sales Lag Estimates, Stock Down
NASDAQ · 5d ago
Viatris (VTRS) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates
NASDAQ · 5d ago
Viatris Inc reports results for the quarter ended in March - Earnings Summary
Viatris Inc reports quarterly adjusted earnings of 67 cents per share for the quarter ended in March. Revenue fell 1.8% to $3.66 billion from a year ago. The company reported quarterly income of $113.9 million. Viatris shares have fallen 1.1% this quarter and gained 9.0% this year.
Reuters · 5d ago
BUZZ-Viatris falls as Q1 revenue misses expectations
Shares of drugmaker Viatris fall 3.4% to $11.40. Company misses first-quarter revenue estimates, hurt by weak sales for its older drugs. Reports Q1 revenue of $3.65 bln, compared with analysts' average estimate of $2.69 bln.
Reuters · 5d ago
VIATRIS SHARES DOWN 3.8% AFTER Q1 REVENUE MISSES ESTIMATES
Reuters · 5d ago
More
Webull provides a variety of real-time VTRS stock news. You can receive the latest news about Viatris Inc Ord Shs through multiple platforms. This information may help you make smarter investment decisions.
About VTRS
Viatris Inc. is a global healthcare company. The Company's segments include Developed Markets, Greater China, JANZ, and Emerging Markets. Its Developed Markets segment comprises its operations primarily in North America and Europe. The Greater China segment includes its operations in China, Taiwan and Hong Kong. The JANZ segment consists of its operations in Japan, Australia and New Zealand. The Emerging Markets segment encompasses its presence in more than 125 countries with developing markets and emerging economies, including in Asia, Africa, Eastern Europe, Latin America and the Middle East, as well as the Company’s ARV franchise. Its portfolio comprises more than 1,400 approved molecules across a range of key therapeutic areas, including key brands and generics, including complex products. It operates around 40 manufacturing sites worldwide that produce oral solid doses, injectables, complex dosage forms and active pharmaceutical ingredients.